Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001493152-26-012941
- Form
- CORRESP
- Filer
- Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592)
- CIK
- 0000748592
- Ticker
- ERNA, ERNAW
- Filed
- 2026-03-26
- SIC industry
- 2834
- HQ
- Cambridge, MA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/748592/000149315226012941/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer